Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
The present invention provides compounds of the formula (I), or the pharmaceutically acceptable salts thereof, wherein G, W, R 2 , R 3 , R 4 , R 5 and R 6 are as defined in the specification. Further objects of the invention are processes and intermediates for the preparation of the compounds of the formula (I), pharmaceutical compositions comprising them and methods for treating cell proliferative disorders. As a matter of fact, the compounds of the formula (I) are useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
1. A compound which is 5-(2-amino-pyrimidin-4-yl)-2-(2,3-dimethyl-phenyl)-1H-pyrrole-3-carboxylic acid amide, or a pharmaceutically acceptable salt thereof.
2. A pharmaceutical composition comprising a therapeutically effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable excipient, carrier or diluent.
3. A pharmaceutical composition according to claim 2 , wherein said composition comprises from about 10 mg to about 1000 mg of said 5-(2-amino-pyrimidin-4-yl)-2-(2,3-dimethyl-phenyl)-1H-pyrrole-3-carboxylic acid amide, or a pharmaceutically acceptable salt thereof.
4. A pharmaceutical composition according to claim 3 , wherein said composition is in the form of a tablet, a capsule, a solution, or a suspension.
5. A pharmaceutical composition according to claim 3 , wherein said composition is in the form of a tablet or capsule.
6. A pharmaceutical composition according to claim 3 , wherein said composition is in the form of a tablet.
7. A pharmaceutical composition according to claim 3 , wherein said composition is in the form of a capsule.